- HSBC pegs India's Balance of Payments deficit much higher, citing damage to Indian exports from Trump's global tariffs.
- Trump's tariffs are negatively affecting H&M and Nike's sales in India, pressuring garment makers.
- Trump imposed arbitrary tariffs and threatened India.
- Trump's tariff plan is pressuring Indian pharmaceutical companies Aurobindo Pharma and Cipla to localize production.
Tariff plan for generic medicines impacted pharma stocks.
3 reports, 3 independent
Updated Jul 22
Gone quiet
Reached 3 outlets in its first 24 hours
- Reports
- 3
- Developments
- 2
- Repetition
- 33%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Tariff plan for generic medicines impacted pharma stocks.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.Trump proposed a new generic drug tariff.1 source
Tariff plan for generic medicines impacted pharma stocks.1 source
Keep exploring
The entities involved
-
Donald Trump
American businessman and politician (born 1946), President of the United States (2017–2021; since 2025)
-
Cipla
Indian multi-national pharmaceutical and biotechnology company
Nothing else this week.
Related events
- Trump, Dimon, and others discussed the threat of massive levies on imported pharmaceuticals while considering financial market trends in Ireland.
- Trump's tariff plan caused market tanking, an event that occurred on August 22, 2025.
- A tariff plan caused market tanking, impacting companies Cintas and United Rentals.
- Trump's tariff plan caused markets to tank, impacting Donnelley Financial Solutions.
- Trump's tariff plan caused markets to tank, affecting company Flo.